바이오칩 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biochips Market size is expected to reach USD 47.28 Billion in 2034 from USD 17.65 Billion (2025) growing at a CAGR of 11.57% during 2026-2034.

The Global Biochips Market is growing rapidly due to increasing applications in genomics, proteomics, and personalized medicine. Biochips enable high-throughput analysis of biological samples, making them essential in disease diagnosis, drug discovery, and research activities. Rising prevalence of chronic diseases and expanding investments in biotechnology research are contributing significantly to market development.

Key drivers include technological advancements in microarray and lab-on-a-chip technologies, as well as growing government support for healthcare innovation. Biochips provide faster and more accurate diagnostic results, which is crucial in precision medicine. Additionally, collaborations between research institutions and biotechnology companies are accelerating product development and commercialization efforts.

Looking ahead, the market is expected to benefit from the increasing adoption of point-of-care testing and advancements in molecular diagnostics. Integration with artificial intelligence and data analytics will enhance analytical capabilities and improve treatment planning. With continued innovation and expanding healthcare needs, the Global Biochips Market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• DNA Chips
• Protein Chips
• Lab-on-chip
• Tissue Arrays
• Cell Arrays

By End Use

• Biotechnology And Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals And Diagnostic Centers
• Others

COMPANIES PROFILED

• Agilent Technologies, PerkinElmer Inc, Illumina Inc, BioRad Laboratories Inc, Standard BioTools, GE HealthCare, IBIOCHIPS, LICOR Inc, Cellix Ltd, Randox Laboratories Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOCHIPS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. DNA Chips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Protein Chips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lab-on-chip Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Tissue Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Cell Arrays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOCHIPS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospitals And Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOCHIPS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOCHIPS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Agilent Technologies
  • 8.2.2 PerkinElmer Inc
  • 8.2.3 Illumina Inc
  • 8.2.4 Bio-Rad Laboratories Inc
  • 8.2.5 Standard BioTools
  • 8.2.6 GE HealthCare
  • 8.2.7 IBIOCHIPS
  • 8.2.8 LI-COR Inc
  • 8.2.9 Cellix Ltd
  • 8.2.10 Randox Laboratories Ltd